{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T19:43:31Z","timestamp":1775504611557,"version":"3.50.1"},"reference-count":15,"publisher":"Japan Endocrine Society","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2022]]},"DOI":"10.1507\/endocrj.ej21-0656","type":"journal-article","created":{"date-parts":[[2022,3,3]],"date-time":"2022-03-03T22:12:41Z","timestamp":1646345561000},"page":"941-945","source":"Crossref","is-referenced-by-count":6,"title":["Switching from the tablet to the powder formulation of levothyroxine corrects severe hypothyroidism in a patient with lactose intolerance"],"prefix":"10.1507","volume":"69","author":[{"given":"Teruo","family":"Jojima","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Metabolism, Dokkyo Medical University, Tochigi 321-0293, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshimitsu","family":"Shinzawa","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Dokkyo Medical University, Tochigi 321-0293, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eriko","family":"Ohira","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Dokkyo Medical University, Tochigi 321-0293, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shintaro","family":"Sakurai","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Dokkyo Medical University, Tochigi 321-0293, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Tomaru","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Dokkyo Medical University, Tochigi 321-0293, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshie","family":"Iijima","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Dokkyo Medical University, Tochigi 321-0293, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiko","family":"Kogai","sequence":"additional","affiliation":[{"name":"Department of Infection Control and Clinical Laboratory Medicine, Dokkyo Medical University, Tochigi 321-0293, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isao","family":"Usui","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Dokkyo Medical University, Tochigi 321-0293, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshimasa","family":"Aso","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Dokkyo Medical University, Tochigi 321-0293, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Hays MT (1991) Localization of human thyroxine absorption. Thyroid 1: 241\u2013248.","DOI":"10.1089\/thy.1991.1.241"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Virili C, Antonelli A, Santaguida MG, Benvenga S, Centanni M (2019) Gastrointestinal malabsorption of thyroxine. Endocr Rev 40: 118\u2013136.","DOI":"10.1210\/er.2018-00168"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 de Carvalho GA, Paz-Filho G, Mesa Junior C, Graf H (2018) Management of endocrine disease: pitfalls on the replacement therapy for primary and central hypothyroidism in adults. Eur J Endocrinol 178: R231\u2013R244.","DOI":"10.1530\/EJE-17-0947"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Mu\u00f1oz-Torres M, Varsavsky M, Alonso G (2006) Lactose intolerance revealed by severe resistance to treatment with levothyroxine. Thyroid 16: 1171\u20131173.","DOI":"10.1089\/thy.2006.16.1171"},{"key":"5","unstructured":"5 Rucha\u0142a M, Szczepanek-Parulska E, Zybek A (2012) The influence of lactose intolerance and other gastro-intestinal tract disorders on L-thyroxine absorption. Endokrynol Pol 63: 318\u2013323."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Cellini M, Santaguida MG, Gatto I, Virili C, Del Duca SC, et al. (2014) Systematic appraisal of lactose intolerance as cause of increased need for oral thyroxine. J Clin Endocrinol Metab 99: E1454\u2013E1458.","DOI":"10.1210\/jc.2014-1217"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Fallahi P, Ferrari SM, Marchi S, De Bortoli N, Ruffilli I, et al. (2017) Patients with lactose intolerance absorb liquid levothyroxine better than tablet levothyroxine. Endocrine 57: 175\u2013178.","DOI":"10.1007\/s12020-016-1090-7"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Marton A, Xue X, Szilagyi A (2012) Meta-analysis: the diagnostic accuracy of lactose breath hydrogen or lactose tolerance tests for predicting the North European lactase polymorphism C\/T-13910. Aliment Pharmacol Ther 35: 429\u2013440.","DOI":"10.1111\/j.1365-2036.2011.04962.x"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Benvenga S (2013) When thyroid hormone replacement is ineffective? Curr Opin Endocrinol Diabetes Obes 20: 467\u2013477.","DOI":"10.1097\/MED.0000000000000003"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Lomer MC, Parkes GC, Sanderson JD (2008) Review article: lactose intolerance in clinical practice\u2014myths and realities. Aliment Pharmacol Ther 27: 93\u2013103.","DOI":"10.1111\/j.1365-2036.2007.03557.x"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Ladas S, Papanikos J, Arapakis G (1982) Lactose malabsorption in Greek adults: correlation of small bowel transit time with the severity of lactose intolerance. Gut 23: 968\u2013973.","DOI":"10.1136\/gut.23.11.968"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Montalto M, Gallo A, Santoro L, D\u2019Onofrio F, Curigliano V, et al. (2008) Low-dose lactose in drugs neither increases breath hydrogen excretion nor causes gastrointestinal symptoms. Aliment Pharmacol Ther 28: 1003\u20131012.","DOI":"10.1111\/j.1365-2036.2008.03815.x"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Asik M, Gunes F, Binnetoglu E, Eroglu M, Bozkurt N, et al. (2014) Decrease in TSH levels after lactose restriction in Hashimoto\u2019s thyroiditis patients with lactose intolerance. Endocrine 46: 279\u2013284.","DOI":"10.1007\/s12020-013-0065-1"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Fallahi P, Ferrari SM, Elia G, Ragusa F, Paparo SR, et al. (2021) L-T4 therapy in enteric malabsorptive disorders. Front Endocrinol (Lausanne) 12: 626371.","DOI":"10.3389\/fendo.2021.626371"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15 Yamamoto T (2003) Tablet formulation of levothyroxine is absorbed less well than powdered levothyroxine. Thyroid 13: 1177\u20131181.","DOI":"10.1089\/10507250360731596"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/69\/8\/69_EJ21-0656\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,3]],"date-time":"2022-09-03T03:49:10Z","timestamp":1662176950000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/69\/8\/69_EJ21-0656\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":15,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej21-0656","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]},"article-number":"EJ21-0656"}}